Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 3045-3052

  Tourkova, Irina L ^a   Shurin, Galina V ^a   Chatta, Gurkamal S ^a,b   Perez, Lori ^a   Finke, James ^c   Whiteside, Theresa L ^a,b   Ferrone, Soldano ^d   Shurin, Michael R ^a,b,e  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; GANGLIOSIDE; GLUCOSYLTRANSFERASE; INTERLEUKIN 15; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEIN ERP57; PROTEIN LMP10; PROTEIN LMP2; PROTEIN LMP7; PROTEIN MB1; RECOMBINANT INTERLEUKIN 15; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUTH CARCINOMA; PRIORITY JOURNAL; REGULATORY MECHANISM; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

EID: 23844552402     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.3045     Document Type: Article

References (44)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Delamarre, L., H. Holcombe, and I. Mellman. 2003. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198: 111-122.
3. Brossart, P., and M. J. Bevan. 1997. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90: 1594-1599.
4. Larsson, M., J. F. Fonteneau, and N. Bhardwaj. 2003. Cross-presentation of cell-associated antigens by dendritic cells. Curr. Top. Microbiol. Immunol. 276: 261-275.
5. Orsini, E., A. Guarini, S. Chiaretti, F. R. Mauro, and R. Foa. 2003. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Res. 63: 4497-4506.
6. Sharma, S., M. Stolina, S. C. Yang, F. Baratelli, J. F. Lin, K. Atianzar, J. Luo, L. Zhu, Y. Lin, M. Huang, et al. 2003. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin. Cancer Res. 9: 961-968.
7. Yang, A. S., and E. C. Lattime. 2003. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses. Cancer Res. 63: 2150-2157.
8. Gabrilovich, D., T. Ishida, T. Oyama, S. Ran, V. Kravtsov, S. Nadaf, and D. P. Carbone. 1998. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92: 4150-4166.
9. Kiertscher, S. M., J. Luo, S. M. Dubinett, and M. D. Roth. 2000. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J. Immunol. 164: 1269-1276.
10. Shurin, M. R., Z. R. Yurkovetsky, I. L. Tourkova, L. Balkir, and G. V. Shurin. 2002. Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. Int. J. Cancer 101: 61-68.
11. Kao, J. Y., Y. Gong, C. M. Chen, Q. D. Zheng, and J. J. Chen. 2003. Tumor-derived TGF-β reduces the efficacy of dendritic cell/tumor fusion vaccine. J. Immunol. 170: 3806-3811.
12. Ladisch, S., Z. L. Wu, S. Feig, L. Ulsh, E. Schwartz, G. Floutsis, F. Wiley, C. Lenarsky, and R. Seeger. 1987. Shedding of GD2 ganglioside by human neuroblastoma. Int. J. Cancer 39: 73-76.
13. Peguet-Navarro, J., M. Sportouch, I. Popa, O. Berthier, D. Schmitt, and J. Portoukalian. 2003. Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis. J. Immunol. 170: 3488-3494.
14. Shurin, G. V., M. R. Shurin, S. N. Bykovskaia, J. Shogan, M. T. Lotze, and E. M. J. Barksdale. 2001. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res. 61: 363-369.
15. Shen, W., and S. Ladisch. 2002. Ganglioside GD1a impedes lipopolysaccharide-induced maturation of human dendritic cells. Cell. Immunol. 220: 125-133.
16. Wolfl, M., W. Y. Batten, C. Posovszky, H. Bernhard, and F. Benhold. 2002. Gangliosides inhibit the development from monocytes to dendritic cells. Clin. Exp. Immunol. 130: 441-448.
17. Caldwell, S., A. Heitger, W. Shen, Y. Liu, B. Taylor, and S. Ladisch. 2003. Mechanisms of ganglioside inhibition of APC function. J. Immunol. 171: 1676-1683.
18. Whiteside, T. L., J. Stanson, M. R. Shurin, and S. Ferrone. 2004. Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. J. Immunol. 173: 1526-1534.
19. Cresswell, P., N. Bangia, T. Dick, and G. Diedrich. 1999. The nature of the MHC class I peptide loading complex. Immunol. Rev. 172: 21-28.
20. Antoniou, A. N., S. J. Powis, and T. Elliott. 2003. Assembly and export of MHC class I peptide ligands. Curr. Opin. Immunol. 15: 75-81.
21. Ackerman, A. L., and P. Cresswell. 2003. Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1. J. Immunol. 170: 4178-4188.
22. Trentin, L., R. Zambello, M. Facco, R. Sancetta, C. Agostini, and G. Semenzato. 1997. Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. Leuk. Lymphoma 27: 35-42.
23. + T cells in vivo by IL-15. Immunity 8: 591-599.
24. Waldmann, T. A., and Y. Tagaya. 1999. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17: 19-49.
25. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167: 1179-1187.
26. Girard, D., M. E. Paquet, R. Paquin, and A. D. Beaulieu. 1996. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood 88: 3176-3184.
27. + Tc1 responses in vivo. Eur. J. Immunol. 34: 66-73.
28. Wang, J., L. Xi, J. L. Hunt, W. Gooding, T. L. Whiteside, Z. Chen, T. E. Godfrey, and R. L. Ferris. 2004. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res. 64: 1861-1866.
29. Aalamian, M., G. Pirtskhalaishvili, A. Nunez, C. Esche, G. V. Shurin, E. Huland, H. Huland, and M. R. Shurin. 2001. Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate 46: 68-75.
30. Ogino, T., X. Wang, and S. Ferrone. 2003. Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulum. J. Immunol. Methods 278: 33-44.
31. Wang, X., B. Liang, V. Rebmann, J. Lu, E. Celis, T. Kageshita, H. Grosse-Wilde, and S. Ferrone. 2003. Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2. Tissue Antigens 62: 139-148.
32. Ladisch, S., and R. Li. 2000. Purification and analysis of gangliosides. Methods Enzymol. 312: 135-145.
33. Tourkova, I. L., Z. R. Yurkovetsky, A. Gambotto, V. P. Makarenkova, L. Perez, L. Balkir, P. D. Robbins, M. R. Shurin, and G. V. Shurin. 2002. Increased function and survival of IL-15-transduced human dendritic cells are mediated by up-regulation of IL-15Rα and Bcl-2. J. Leukocyte Biol. 72: 1037-1045.
34. Gabrilovich, D. I., J. Corak, I. F. Ciernik, D. Kavanaugh, and D. P. Carbone. 1997. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3: 483-490.
35. Ratta, M., F. Fagnoni, A. Curti, R. Vescovini, P. Sansoni, B. Oliviero, M. Fogli, E. Ferri, G. R. Della Cuna, S. Tura, et al. 2002. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood 100: 230-237.
36. Troy, A., P. Davidson, C. Atkinson, and D. Hart. 1999. Renal cell carcinoma and prostate cancer inhibit dendritic cell activation. Aust. NZJ Surg. 69: A111.
37. Nestle, F. O., G. Burg, J. Fah, T. Wrone-Smith, and B. J. Nickoloff. 1997. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell costimulatory molecules and are impaired as antigen-presenting cells. Am. J. Pathol. 150: 641-651.
38. Tas, M. P., P. J. Simons, F. J. Balm, and H. A. Drexhage. 1993. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones. Cancer Immunol. Immunother. 36: 108-114.
39. Thurnher, M., C. Radmayr, R. Ramoner, S. Ebner, G. Bock, H. Klocker, N. Romani, and G. Bartsch. 1996. Human renal-cell carcinoma tissue contains dendritic cells. Int. J. Cancer 68: 1-7.
40. Macagno, A., M. Gilliet, F. Sallusto, A. Lanzavecchia, F. O. Nestle, and M. Groettrup. 1999, Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur. J. Immunol. 29: 4037-4042.
41. Li, J., B. Schuler-Thurner, G. Schuler, C. Huber, and B. Seliger. 2001. Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation. Int. Immunol. 13: 1515-1523.
42. Shurin, G. V., Z. R. Yurkovetsky, and M. R. Shurin. 2003. Tumor-induced dendritic cell dysfunction. In Mechanisms of Tumor Escape from the Immune Response. A. Ochoa, ed. Taylor and Francis, London and New York, p. 112-138.
43. McKallip, R., R. Li, and S. Ladisch. 1999. Tumor gangliosides inhibit the tumor-specific immune response. J. Immunol. 163: 3718-3726.
44. Ohteki, T., K. Suzue, C. Maki, T. Ota, and S. Koyasu. 2001. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol. 2: 1138-1143.